Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
September 30, 2026 -0.202M
June 30, 2026 -0.223M
March 31, 2026 -0.154M
December 31, 2025 -0.656M
September 30, 2025 -0.267M
June 30, 2025 -0.157M
March 31, 2025 0.146M
December 31, 2024 -0.237M
September 30, 2024 -0.058M
June 30, 2024 -0.046M
March 31, 2024 -0.129M
December 31, 2023 -0.087M
September 30, 2023 -0.133M
June 30, 2023 -0.441M
March 31, 2023 -0.558M
December 31, 2022 -0.461M
September 30, 2022 -0.256M
June 30, 2022 -0.459M
March 31, 2022 -0.486M
December 31, 2021 -0.31M
September 30, 2021 -0.27M
June 30, 2021 -0.2399M
March 31, 2021 -0.0643M
December 31, 2020 -0.0624M
September 30, 2020 -0.0815M
Date Value
June 30, 2020 -0.1269M
March 31, 2020 -0.1496M
December 31, 2019 -0.2853M
September 30, 2019 -0.4155M
June 30, 2019 -1.146M
March 31, 2019 -0.0896M
December 31, 2018 -0.1189M
September 30, 2018 -0.0322M
June 30, 2018 -0.1646M
March 31, 2018 -0.1689M
December 31, 2017 -0.1358M
September 30, 2017 -0.1024M
June 30, 2017 -0.2012M
March 31, 2017 -0.1743M
December 31, 2016 -0.2407M
September 30, 2016 -0.071M
June 30, 2016 -0.295M
March 31, 2016 -0.0855M
December 31, 2015 -0.0842M
September 30, 2015 -0.1148M
June 30, 2015 -0.2449M
March 31, 2015 -0.0938M
December 31, 2014 -0.1291M
September 30, 2014 -0.1567M
June 30, 2014 -0.3013M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Stereotaxis, Inc. -2.952M
Accuray, Inc. -5.004M
Orthofix Medical, Inc. -14.24M
ResMed, Inc. 392.06M
Rockwell Medical, Inc. 1.756M